Cargando…

Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity

Although the respiratory tract is the primary site of SARS-CoV-2 infection and the ensuing immunopathology, respiratory immune responses are understudied and urgently needed to understand mechanisms underlying COVID-19 disease pathogenesis. We collected paired longitudinal blood and respiratory trac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wuji, Chua, Brendon, Selva, Kevin, Kedzierski, Lukasz, Ashhurst, Thomas, Haycroft, Ebene, Shoffner, Suzanne, Hensen, Luca, Boyd, David, James, Fiona, Mouhtouris, Effie, Kwong, Jason, Chua, Kyra, Drewett, George, Copaescu, Ana, Dobson, Julie, Rowntree, Louise, Habel, Jennifer, Allen, Lilith, Koay, Hui-Fern, Neil, Jessica, Gartner, Matthew, Lee, Christina, Andersson, Patiyan, Seemann, Torsten, Sherry, Norelle, Amanat, Fatima, Krammer, Florian, Londrigan, Sarah, Wakim, Linda, King, Nicholas, Godfrey, Dale, Mackay, Laura, Thomas, Paul, Nicholson, Suellen, Arnold, Kelly, Chung, Amy, Holmes, Natasha, Smibert, Olivia, Trubiano, Jason, Gordon, Claire, Nguyen, Thi, Kedzierska, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404907/ https://www.ncbi.nlm.nih.gov/pubmed/34462740 http://dx.doi.org/10.21203/rs.3.rs-802084/v1

Ejemplares similares

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2022)

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021)

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021)

Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication
por: Gordon, Claire L, et al.
Publicado: (2021)

Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
por: Nguyen, Thi H.O., et al.
Publicado: (2021)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
por: Drewett, George P., et al.
Publicado: (2021)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

Are NKT cells a useful predictor of COVID-19 severity?
por: Koay, Hui-Fern, et al.
Publicado: (2022)

Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
por: Habel, Jennifer R., et al.
Publicado: (2023)

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol
por: Copaescu, Ana-Maria, et al.
Publicado: (2022)

The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study
por: Trubiano, Jason A, et al.
Publicado: (2018)

Staff to staff transmission as a driver of healthcare worker infections with COVID-19
por: Gordon, Claire L., et al.
Publicado: (2021)

Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy
por: Nguyen, Thi H. O., et al.
Publicado: (2023)

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
por: Rowntree, Louise C, et al.
Publicado: (2021)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
por: Copaescu, Ana, et al.
Publicado: (2021)

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
por: Koutsakos, Marios, et al.
Publicado: (2021)

1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018)

Validation of the PEN-FAST Score in a Pediatric Population
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

COVID-Care – a safe and successful digital self-assessment tool for outpatients with proven and suspected coronavirus-2019
por: Drewett, George P, et al.
Publicado: (2021)

Surveillance for SARS‐CoV‐2 variants of concern in the Australian context
por: Andersson, Patiyan, et al.
Publicado: (2021)

1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study
por: Smibert, Olivia, et al.
Publicado: (2018)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
por: Hall, Victoria G, et al.
Publicado: (2023)

Suboptimal SARS-CoV-2−specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype
por: Habel, Jennifer R., et al.
Publicado: (2020)

2743. Pre-Transplant Human T-Lymphotropic Virus Screening In Allogeneic Hematopoietic Stem Cell Transplant Recipients At A Large Metropolitan Tertiary Referral Centre In Melbourne, Australia
por: Paykin, Gabriel, et al.
Publicado: (2023)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses
por: Auladell, Maria, et al.
Publicado: (2019)

Phenotypic distribution and tolerability of re-vaccination in individuals with delayed hypersensitivity to COVID-19 vaccines
por: De Luca, Joseph, et al.
Publicado: (2023)

Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
por: Farr, Ryan J., et al.
Publicado: (2021)

Viral burden, inflammatory milieu and CD8(+) T‐cell responses to influenza virus in a second‐generation thiazolide (RM‐5061) and oseltamivir combination therapy study
por: Nüssing, Simone, et al.
Publicado: (2020)

High expression of CD38 and MHC class II on CD8(+) T cells during severe influenza disease reflects bystander activation and trogocytosis
por: Jia, Xiaoxiao, et al.
Publicado: (2021)

Shared Decision-Making for Nursing Practice: An Integrative Review
por: Truglio-Londrigan, Marie, et al.
Publicado: (2018)

New rules for genomics-informed COVID-19 responses–Lessons learned from the first waves of the Omicron variant in Australia
por: Porter, Ashleigh F., et al.
Publicado: (2022)

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells
por: Nguyen, Thi H.O., et al.
Publicado: (2023)

Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity
por: Wang, Zhongfang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jndc5u4703v0ijlpf3u91qbaho